© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 161 Farringdon Rd, London EC1R 3AL. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

Market News

Top Section/Ad

Top Section/Ad

Most recent


Europe’s self-proclaimed investment banking champions are playing to their strengths, but remain far behind US peers
After quitting M&A and equity capital markets in Europe and the US last year, HSBC is striving to maintain global relevance — and London and New York still have a role to play
Deal raises questions about whether transaction was done at arm's length
Public pension schemes have sold shares in coal, oil and gas companies but are still funding expansion of the gas industry through infrastructure funds
More articles/Ad

More articles/Ad

More articles

  • Myanmar has moved closer to an offshore bond issue after circulating a draft law clarifying how the sovereign can raise debt, and hiring Citi and Standard Chartered as ratings advisers. The moves have been welcomed but investors have been warned to expect a long wait before they get their hands on any deal, writes Shruti Chaturvedi.
  • Regulators in Europe, the US and Canada are likely to continue to make changes to the liquidity coverage ratio and high quality liquid assets frameworks to ensure they do not lead to unintended distortions, said Standard & Poor’s analysts in a recent report.
  • SSA
    China’s decision to devalue its currency this week will add another complication to what is already a troublesome time in the public sector bond market — just as a separate source of woe for SSA bankers looked to be resolved.
  • Many market participants decamp to Cornwall for their summer breaks - in fact it is seemingly where the whole market has absconded to over the last couple of weeks, but with varying results.
  • The State Bank of Pakistan (SBP) has put together a draft framework to identify, regulate and supervise its domestic systemically important banks (D-SIBs).
  • Alkem Laboratories, a drug manufacturer, has lodged its preliminary prospectus with India’s regulator for a listing that could raise some $200m. The trade will be led by two local and two international banks.